L.A.B. Golf, the hottest putter company in golf and an overnight sensation nearly a decade in the making, just had its ...

The private equity industry wants to get into your 401(k). The industry is lobbying the Trump administration to issue an executive order that would open the way for retirement plans to add private ...

President Donald Trump is considering an executive order to open retirement plans up to private equity and alternative investments. Here are a few key considerations.

Private equity is seeing a shift away from renewable energy projects, which have largely stalled in a much-changed policy landscape. Instead, that now-freed up capital comes back to oil.

FTI Consulting's 2025 Private Equity Value Creation Index reveals M&A as a low priority, while AI gains prominence in value creation.

After Prospect Medical Holdings declared bankruptcy, lawmakers wanted to rein in private equity in CT health care. But no bills passed.

In her new book “Bad Company,” journalist Megan Greenwell chronicles how private equity upended industries from health care to local news—and the ways workers are fighting back.

How do I know we have reached peak private equity? Because it has become the primary villain of the U.S. economy—responsible for the high cost of everything from housing to healthcare. Many of ...

The secondary market for private equity stakes is booming as buyers are eager to snap up assets being shed by investors. There’s reason to believe Harvard, Yale, and other elite institutions ...

Pennsylvania lawmakers move to regulate private equity deals in health care, but a bill faces hurdles in the Senate House lawmakers from Delaware County are leading efforts to regulate private equity ...

Like many other companies, private equity firms are interested in AI as a tool for faster value creation. And like other companies, the results have been mixed, as few report significant returns ...

Turkish private equity firm commits $39 million to support research by Gökhan Hotamışlıgil, with option to invest in future drug candidates from his lab.